Autopsy report · NCT00882193

Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/Relapsers

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“new medications with improved response released”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 1 year 8 months before it stopped.
2 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Early Phase 1
Sponsor: University of Nebraska
Sponsor type: University, hospital or other
Conditions: Chronic Hepatitis C; Genotype 1; Relapse
Interventions: Betaine; Peginterferon alpha 2a; Ribavirin
Participants: 2
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.